Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 27;15(1):51.
doi: 10.1186/s12985-018-0967-x.

Genotype-specific and cross-reactive neutralizing antibodies induced by dengue virus infection: detection of antibodies with different levels of neutralizing activities against homologous and heterologous genotypes of dengue virus type 2 in common marmosets (Callithrix jacchus)

Nor Azila Muhammad Azami  1   2 , Meng Ling Moi  1   3 , Yasushi Ami  4 , Yuriko Suzaki  4 , Chang-Kweng Lim  1 , Satoshi Taniguchi  1 , Masayuki Saijo  1 , Tomohiko Takasaki  5 , Ichiro Kurane  6
Affiliations

Genotype-specific and cross-reactive neutralizing antibodies induced by dengue virus infection: detection of antibodies with different levels of neutralizing activities against homologous and heterologous genotypes of dengue virus type 2 in common marmosets (Callithrix jacchus)

Nor Azila Muhammad Azami et al. Virol J. .

Abstract

Background: A vaccine against all four dengue virus (DENV) serotypes includes the formulation of one genotype of each serotype. Although genetic similarities among genotypes within a serotype are higher as compared to those among serotypes, differences in the immunogenicity of the included genotypes would be a critical issue in maximizing successful dengue vaccine development. Thus, we determined the neutralizing antibody responses against three genotypes of dengue virus serotype 2 (DENV-2), namely Cosmopolitan, Asian I, and Asian/American, after primary and secondary inoculation with DENV-2 in a dengue animal model, the common marmoset (Callithrix jacchus).

Methods: A total of fifty-four plasma samples were obtained from thirty-four marmosets that were inoculated with clinically-isolated DENV strains or DENV candidate vaccines, were used in this study. Plasma samples were obtained from marmosets after primary inoculation with DENV-2 infection, secondary inoculation with homologous or heterologous genotypes, and tertiary inoculation with heterologous DENV. Neutralizing antibody titers against DENV-2 (Cosmopolitan, Asian I, and Asian/American genotypes) and DENV-1 were determined using a conventional plaque reduction neutralization assay.

Results: In marmosets that were inoculated with the Cosmopolitan genotype in primary infection, neutralizing antibody neutralized 3 genotypes, and the titers to Asian I genotype were significantly higher than those to homologous Cosmopolitan genotype. After secondary DENV-2 infection with heterologous genotype (Asian I in primary and Asian/American in secondary), neutralizing antibody titers to Asian/American genotype was significantly higher than those against Cosmopolitan and Asian I genotypes. Following tertiary infection with DENV-1 following DENV-2 Asian I and Cosmopolitan genotypes, neutralizing antibody titers to Asian/American were also significantly higher than those against Cosmopolitan and Asian I genotypes.

Conclusion: The present study demonstrated that different levels of neutralizing antibodies were induced against variable DENV-2 genotypes after primary, secondary and tertiary infections, and that neutralizing antibody titers to some heterologous genotypes were higher than those to homologous genotypes within a serotype. The results indicate that heterogeneity and homogeneity of infecting genotypes influence the levels and cross-reactivity of neutralizing antibodies induced in following infections. The results also suggest that certain genotypes may possess advantage in terms of breakthrough infections against vaccination.

Keywords: Animal model; Antibody response; Dengue; Genotype.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

The animal studies were conducted in accordance with the guidelines of the Institutional Animal Care and Use Committee of the National Institute of Infectious Diseases (NIID), Tokyo, Japan. The study was approved by the Institutional Animal Care and Use Committee of NIID (approval no. 613006 and 516,010). All animal and infection experiments were performed according to the NIID Institutional Guidelines, in additions to the guidelines of the Science Council, and local rules and regulations.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Neutralizing antibodies titers to DENV-2 genotypes (Cosmopolitan, Asian I and Asian/American) during primary DENV inoculation. Neutralizing antibody titers in marmosets inoculated with: a DENV-2 genotype Cosmopolitan, b DENV-2 genotype Asian I, c DENV-2 genotype Asian/American, d DENV-1 genotype I, e DENV-1 genotype II. Double asterisks (**) indicate that there were statistically significant differences (p < 0.05) in the titers of neutralizing antibodies between genotypes. Student’s test analysis was used to determine the differences in mean titers of neutralizing antibody between CM vs AI, CM vs AA, and AI vs AA. CM indicates Cosmopolitan genotype. A1 indicates Asian I genotype. AA indicates Asian/American genotype
Fig. 2
Fig. 2
Neutralizing antibodies titers to DENV-2 genotypes (Cosmopolitan, Asian I and Asian/American) after secondary DENV inoculation. Neutralizing antibody titers in marmosets inoculated with: a Homologous DENV-2 genotype(Cosmopolitan), b Heterologous DENV-2 genotypes (Asian1 in primary, Cosmopolitan in secondary), c two DENV-1 genotypes (Genotype 1 in primary, Genotype II in secondary), d Neutralizing antibody titers to DENV-1 genotype I during two DENV-1 genotypes (Genotype 1 in primary, Genotype II in secondary), e Heterologous serotypes (DENV-2 Asian1 genotype in primary, DENV-1 Genotype 1 in secondary), f Neutralizing antibody titers to DENV-1 genotype I after inoculation with heterologous serotypes (DENV-2 Asian1 genotype in primary, DENV-1 Genotype 1 in secondary). Double asterisks (**) indicates that there were statistically significant differences (p < 0.05) in the titers of neutralizing antibodies between genotypes. Student’s test analysis was used to determine the differences in mean titers of neutralizing antibody between CM vs AI, CM vs AA, and AI vs AA. Neutralizing antibody data at day 365 post-inoculation of (b) are the same data as day0 of Fig. 4b. CM indicates Cosmopolitan genotype, A1 indicates Asian I genotype and AA indicates Asian/American genotype
Fig. 3
Fig. 3
Neutralizing antibodies titers to DENV-2 genotypes (Cosmopolitan, Asian I and Asian/American) in marmosets inoculated with candidate dengue vaccines and challenged with isolated DENV. Neutralizing antibody titers in marmosets inoculated with: a Candidate vaccine DENV-2 16,881 PDK-53, b Candidate vaccine DENV-2 16,881 PDK-53 in primary and with DENV-2 genotype Cosmopolitan in secondary, c Vaccine candidate DENV-1 16,007 PDK-13, d Vaccine candidate DENV-1 16,007 PDK-13 in primary and DENV-1 genotype I in secondary. Double asterisks (**) indicate that there were statistically significant differences (p < 0.05) in the titers of neutralizing antibodies between genotypes. Student’s test analysis was used to determine the differences in mean titers of neutralizing antibody between CM vs AI, CM vs AA, and AI vs AA. CM indicates Cosmopolitan genotype. A1 indicates Asian I genotype. AA indicates Asian/American genotype
Fig. 4
Fig. 4
Neutralizing antibodies titers to DENV-2 genotypes (Cosmopolitan, Asian I and Asian/American) after tertiary inoculation. a Marmosets which had been first inoculated with DENV-2 16,881 PDK-53 (Asian I genotype) and then challenged with DENV-2 genotype Cosmopolitan were infected with DENV-1 in tertiary inoculation. b Neutralizing antibody titers to DENV-1, genotype 1 in the same marmosets in (a). c Marmosets that were first inoculated with the DENV-2 Asian I genotype and then challenged with the DENV-2 genotype Cosmopolitan were infected with DENV-1 genotype I in tertiary inoculation. d Neutralizing antibody titers to DENV-1, genotype 1 in the same marmosets in (c). Double asterisks (**) indicate that there were statistically significant differences (p < 0.05) in the titers of neutralizing antibodies between genotypes. Student’s test analysis was used to determine the differences in mean titers of neutralizing antibody between CM vs AI, CM vs AA, and AI vs AA. CM indicates Cosmopolitan genotype. A1 indicates Asian I genotype. AA indicates Asian/American genotype
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Halstead S. Dengue. 2008.
    1. Guzman MC, Halstead SB, Artsob H, Buchy P, Jeremy F, Gubler DJ, et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010;8:S7–16. doi: 10.1038/nrmicro2460. - DOI - PMC - PubMed
    1. WHO . Dengue guidelines for diagnosis, treatment, prevention and control: new edition. Geneva: World Health organization; 2009. - PubMed
    1. Waman VP, Kolekar P, Ramtirthkar MR, Kale MM, Kulkarni-Kale U. Analysis of genotype diversity and evolution of dengue virus serotype 2 using complete genomes. PeerJ. 2016;4:e2326. doi: 10.7717/peerj.2326. - DOI - PMC - PubMed
    1. Usme-Ciro JA, Méndez JA, Laiton KD, Páez A. The relevance of dengue virus genotypes surveillance at country level before vaccine approval. Hum Vaccin Immunother. 2014;10:2674–2678. doi: 10.4161/hv.29563. - DOI - PMC - PubMed

Publication types

MeSH terms